Ofer Levy MD
Professor, Pediatrics-Children's Hospital, Harvard Medical School
Join to View Full Profile
300 Longwood AveBoston, MA 02115
Phone+1 617-919-2900
Fax+1 617-730-0255
Dr. Levy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ofer Levy is a pediatric infectious disease specialist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital (BCH) and Brigham and Women's Hospital. He received his medical degree from NYU Grossman School of Medicine and has been in practice 20 years. He directs the Precision Vaccines Program at BCH and serves on the U.S. FDA Vaccines & Related Biologic Products Advisory Committee. He has 180 publications and a Google Scholar H index of 63. Dr. Levy and his research have been featured on CNN, FOXNews, NBC, the New York Times, USA Today and Scientific American.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 2000 - 2003- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1997 - 2000
New York University School of MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2003 - 2026
American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Berson Research Award New York University School of Medicine, 2018
Clinical Trials
- Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity Start of enrollment: 2017 Sep 06
Publications & Presentations
PubMed
- Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns.Avy Violari, Kennedy Otwombe, William Hahn, Shiyu Chen, Deirdre Josipovic
The Journal of Clinical Investigation. 2025-04-03 - Correction: Respiratory infection‑ and asthma‑prone, low vaccine responder children demonstrate distinct mononuclear cell DNA methylation pathways.David Martino, Nikki Schultz, Ravinder Kaur, Simon D van Haren, Nina Kresoje
Clinical Epigenetics. 2025-03-28 - BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in mice.Matthew E Sherman, Jane Michalski, Sayan Das, Hyojik Yang, Lakshmi Chandrasekaran
Vaccine. 2025-03-19
Journal Articles
- Increasing FIM2/3 Antigen-Content Improves Efficacy of Bordetella Pertussis Vaccines in Mice in Vivo Without Altering Vaccine-Induced Human Reactogenicity Biomarkers i...Ofer Levy, MD, ScienceDirect
Press Mentions
FDA Appears to Be Slow-Walking Vaccine ApprovalsApril 28th, 2025
Kennedy Falsely Claims Measles Vaccine Protection 'Wanes Very Quickly'April 11th, 2025
Ofer Levy, MD, PhD: Innovator in Vaccine Research and Pediatric Infectious Diseases at Boston Children’s HospitalMarch 12th, 2025- Join now to see all
Grant Support
- VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)BOSTON CHILDREN'S HOSPITAL2024–2029
- VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)BOSTON CHILDREN'S HOSPITAL2024–2029
- Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthmaBOSTON CHILDREN'S HOSPITAL2022–2027
- Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthmaBOSTON CHILDREN'S HOSPITAL2022–2027
- Immune development in early life (IDEAL) shapes vaccine response, respiratory infectious diseaseand asthmaBOSTON CHILDREN'S HOSPITAL2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
